IL96667A0 - Pharmaceutical compositions containing fibroblast growth factors for the prevention and treatment of viral infections - Google Patents

Pharmaceutical compositions containing fibroblast growth factors for the prevention and treatment of viral infections

Info

Publication number
IL96667A0
IL96667A0 IL96667A IL9666790A IL96667A0 IL 96667 A0 IL96667 A0 IL 96667A0 IL 96667 A IL96667 A IL 96667A IL 9666790 A IL9666790 A IL 9666790A IL 96667 A0 IL96667 A0 IL 96667A0
Authority
IL
Israel
Prior art keywords
prevention
treatment
pharmaceutical compositions
growth factors
compositions containing
Prior art date
Application number
IL96667A
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of IL96667A0 publication Critical patent/IL96667A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL96667A 1989-12-22 1990-12-14 Pharmaceutical compositions containing fibroblast growth factors for the prevention and treatment of viral infections IL96667A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT02280489A IT1237795B (en) 1989-12-22 1989-12-22 FIBROBLASTIC GROWTH FACTORS FOR USE IN THE PREVENTION AND TREATMENT OF VIRAL INFECTIONS.

Publications (1)

Publication Number Publication Date
IL96667A0 true IL96667A0 (en) 1991-09-16

Family

ID=11200616

Family Applications (1)

Application Number Title Priority Date Filing Date
IL96667A IL96667A0 (en) 1989-12-22 1990-12-14 Pharmaceutical compositions containing fibroblast growth factors for the prevention and treatment of viral infections

Country Status (10)

Country Link
EP (1) EP0460161A1 (en)
JP (1) JPH04504581A (en)
AU (1) AU632890B2 (en)
CA (1) CA2047203A1 (en)
HU (1) HUT62197A (en)
IE (1) IE904593A1 (en)
IL (1) IL96667A0 (en)
IT (1) IT1237795B (en)
WO (1) WO1991009610A1 (en)
ZA (1) ZA9010337B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714458A (en) * 1990-07-18 1998-02-03 Farmitalia Carlo Erba S.R.L. Stable pharmaceutical compositions containing a fibroblast growth factor
ES2305138T3 (en) * 2000-11-27 2008-11-01 Dnavec Research Inc. PARAMIXOVIRUS VECTOR CODIFYING FIBROBLAST GROWTH FACTOR 2 (FGF2) AND USE OF IT.
JP6363833B2 (en) * 2013-11-22 2018-07-25 ナノシータ株式会社 Thin film polymer structure

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987001728A1 (en) * 1985-09-12 1987-03-26 Biotechnology Research Partners, Ltd. Recombinant fibroblast growth factors
US4929442A (en) * 1986-09-26 1990-05-29 Exovir, Inc. Compositions suitable for human topical application including a growth factor and/or related materials

Also Published As

Publication number Publication date
ZA9010337B (en) 1991-10-30
IT8922804A0 (en) 1989-12-22
EP0460161A1 (en) 1991-12-11
IT1237795B (en) 1993-06-17
JPH04504581A (en) 1992-08-13
HUT62197A (en) 1993-04-28
IE904593A1 (en) 1991-07-03
AU632890B2 (en) 1993-01-14
AU6970491A (en) 1991-07-24
WO1991009610A1 (en) 1991-07-11
CA2047203A1 (en) 1991-06-23
HU913022D0 (en) 1992-01-28

Similar Documents

Publication Publication Date Title
ZA896864B (en) Method and composition for the treatment and prevention of viral infections
IL91307A0 (en) Hiv protease inhibitors and pharmaceutical compositions for the treatment of aids containing them
IL89900A0 (en) Hiv protease inhibitors useful for the treatment of aids and pharmaceutical compositions containing them
IL86089A (en) Pharmaceutical compositions containing certain androstane-17-ones for the prophylaxis and therapy of retroviral infections
GB8900678D0 (en) Compositions for the prevention and medical treatment of parodonthopathy
IL111338A0 (en) Pharmaceutical or veterinary compositions comprising flavin derivatives for the treatment of viral infections and their preparation
EP0382551A3 (en) Prevention and treatment of herpes virus infections
HU903011D0 (en) Process for the preparation of cyclopeptides and pharmaceutical compositions containing them
IL96667A0 (en) Pharmaceutical compositions containing fibroblast growth factors for the prevention and treatment of viral infections
AU6527390A (en) Pharmaceutical compositions for the treatment of ataxy and equilibrium problems
IL93242A0 (en) Pharmaceutical preparation for the treatment of tonsillitis
GB2255718B (en) Pharmaceutical composition for treating bacterial and / or viral infection
IL96455A0 (en) Pharmaceutical compositions for the treatment of hsv
IL102815A0 (en) Pharmaceutical compositions and method for the treatment of infection caused by the human immunodeficiency virus
AU4787793A (en) Extract and pharmaceutical composition for treatment of calcium oxalate stone disease and viral infections
EP0452360A4 (en) Methods and compositions for the prophylaxis and treatment of hepatitis b virus infections
HU896636D0 (en) Process for the preparation of polyhydroxy-benzyloxypropanolamines and pharmaceutical compositions thereof
GB9111885D0 (en) Nerve growth factor for use in the prevention and treatment of viral infections
OA09507A (en) Compositions and methods for treating or preventing AIDS ARC and HIV infection
IL84550A (en) Pharmaceutical compositions for treatment of viral infections containing 3( -fluoro-3(-deoxy-thymidine
IL106939A0 (en) Pharmaceutical compositions for treating viral infections
ZA896503B (en) Pharmaceutical combination preparations and their use for the prophylaxis or treatment of bacterial infectious diseases
LTIP472A (en) Composition for the treatment of infection and disease caused by hepatit b virus
GB8908866D0 (en) Pharmaceutical compositions and treatment
ZA865017B (en) A pharmaceutical composition for the treatment and/or prophylaxis of hyperglycaemia